Clinical trial
DBT and Escitalopram in Borderline Personality Disorder
NCT00255554 · Bronx VA Medical Center, U.S. Fed · Unknown status
Key facts
| NCT number | NCT00255554 |
|---|---|
| Title | DBT and Escitalopram in Borderline Personality Disorder |
| Official title | Effects of Dialectical Behavioral Therapy and Escitalopram on Impulsive Aggression, Affective Instability and Cognitive Processing in Borderline Personality Disorder |
| Lead sponsor | Bronx VA Medical Center, U.S. Fed |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Borderline Personality Disorder |
| Intervention type | Behavioral, Drug |
| Interventions | Dialectical Behavioral Therapy, Escitalopram |
| First posted | Nov 21, 2005 |
| Last update posted | Nov 21, 2005 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: